Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Transitional Cell

Explore clinical trials studying Carcinoma, Transitional Cell. Study availability and eligibility vary by location and protocol.

417 public trials 125 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Transitional Cell trial results

Active, Not Recruiting

A Study of the Safety and Efficacy of Various Combinations of Avelumab as Therapy in Locally Advanced or Metastatic Urothelial Carcinoma (JAVELIN Bladder Medley)

NCT05327530

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +13 more
Locations
  • Beacon Cancer Care Coeur d'Alene, Idaho, United States
  • University of Kansas Medical Center Research Institute, Inc. - 3901 Rainbow (MAIN) Kansas City, Kansas, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • The Johns Hopkins Hospital Baltimore, Maryland, United States
View all 97 locations
View Trial Details
Active, Not Recruiting

Pembrolizumab in Muscle-invasive Bladder Cancer

NCT05406713

Conditions
Carcinoma, Carcinoma, Transitional Cell, Localized Cancer, +5 more
Locations
  • City of Hope Duarte, California, United States
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
  • University of New Mexico Comprehensive Cancer Center Albuquerque, New Mexico, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
View Trial Details
Active, Not Recruiting

A Study of Two Dosing Schedules of Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment for Metastatic Bladder Cancer

NCT03093922

Conditions
Carcinoma, Carcinoma, Transitional Cell, Locally Advanced, +5 more
Locations
  • University of Chicago Chicago, Illinois, United States
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
View Trial Details
Active, Not Recruiting

Neoadjuvant Nivolumab With and Without Urelumab in Cisplatin-Ineligible or Chemotherapy-refusing Patients With Muscle-Invasive Urothelial Carcinoma of the Bladder

NCT02845323

Conditions
Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +14 more
Locations
  • UCLA Institute of Urologic Oncology Los Angeles, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • University of Chicago Chicago, Illinois, United States
  • Johns Hopkins Hospital Baltimore, Maryland, United States
View Trial Details
Active, Not Recruiting

A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder Cancer

NCT02138734

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +14 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Alaska Clinical Research Center Anchorage, Alaska, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • Center for Neurosciences Tucson, Arizona, United States
View all 108 locations
View Trial Details
Active, Not Recruiting

A Study of Erdafitinib in Participants With Metastatic or Locally Advanced Urothelial Cancer

NCT03473743

Conditions
Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +3 more
Locations
  • Rocky Mountain Cancer Centers Aurora, Colorado, United States
  • Norton Cancer Institute Louisville, Kentucky, United States
  • Maryland Oncology Hematology, PA Rockville, Maryland, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
View all 127 locations
View Trial Details

Related conditions